Product Image

Vital Brain Powder

Vital Nutrients
4.7
★ ★ ★ ★ ★
(20 ratings)
Acetyl L-Carnitine 850 mg
Alpha-GPC 600 mg
Product Image
Score73
A deep three-ingredient cognitive stack with meaningful ALCAR, Alpha-GPC, and phosphatidylserine. Strong coverage comes with uncertain Alpha-GPC yield and premium value.
How scoring works
Quantity:150 Gram(s) • (30 servings)
Goals:
Productivity Boost
Cognitive Support
Mental Focus
Brain Health
Energy
Anti-Aging
Metabolism Boost

Score 73

A deep three-ingredient cognitive stack with meaningful ALCAR, Alpha-GPC, and phosphatidylserine. Strong coverage comes with uncertain Alpha-GPC yield and premium value.
How scoring works
$94.99($3.16 per serving)
Pure Formulas
$ 94.99
iHerb
$ 0.00
Report prices

Analysis

ALCAR supports mitochondrial brain energy, Alpha-GPC supplies a choline-oriented pathway, and phosphatidylserine targets cell membranes. All three are present at material amounts rather than token additions.

The ALCAR hydrochloride amount is strong and clearly stated. Alpha-GPC source and active yield are not clarified, so the listed weight may not equal pure Alpha-GPC.

A scoop-based powder allows convenient combined use without stimulants. Moisture handling and premium serving value are practical drawbacks, especially for users who need only one of the three actives.

Who is it for
  • Adults seeking a non-stimulant cognitive stack
  • Users wanting brain energy, choline, and membrane support together
Best for
  • Mental focus and cognitive-stamina routines
  • Combining three substantial brain actives

Pros

  • Strong ALCAR amount
  • Meaningful phosphatidylserine
  • Alpha-GPC reaches a potentially useful active contribution

Cons

  • Alpha-GPC active yield is not stated
  • Premium serving cost
  • Powder requires careful moisture protection

Warnings

  • Cholinergic ingredients may cause headache or nausea
  • ALCAR may feel stimulating to sensitive users
  • Measure powder carefully and keep it dry

Nutrient quality

93 Highest impact

Three well-chosen cognitive actives provide meaningful, complementary amounts. The focused design avoids obvious filler and has no clear overdosing concern.

.

Ingredient transparency

82 Highest impact

All active amounts are clearly disclosed without a hidden blend. Daily-use directions and non-active powder ingredients are not supplied.

.

Customer satisfaction

61 Moderate impact

The available rating is strong and the sample is small. Detailed feedback was not supplied, so repeated complaints and alignment with the intended use remain uncertain.

.

Value for money

47 Lower impact

Excellent ingredient quality only partly supports the premium position. The short supply makes effective serving value weak compared with similar cognitive formulas.

.
Report analysis

Goals

Productivity Boost
Productivity Boost
Impact
Highest effect
A- Goal FitA- Strength of SupportA- CoverageA+ Formula Quality
Acetyl L-Carnitine · 850 mgAcetyl L-Carnitine · 850 mgAlpha-GPC · 600 mg

The three-ingredient brain formula is strongly aligned with mental energy, focus, and cognitive stamina. Acetyl-L-carnitine, Alpha-GPC, and phosphatidylserine each reach meaningful amounts and address complementary functions.

All amounts are disclosed, although Alpha-GPC active yield and ingredient sourcing are not clarified. The focused design offers substantial depth without stimulants or unrelated filler ingredients.

Study evidence
Acetyl L-Carnitine Supportive 1 study
Acetyl L-Carnitine Supportive 1 study
Alpha-GPC Supportive 2 studies
Cognitive Support
Cognitive Support
Impact
Highest effect
A Goal FitB+ Strength of SupportA- CoverageA+ Formula Quality
Acetyl L-Carnitine · 850 mgAlpha-GPC · 600 mg

Acetyl-L-carnitine, Alpha-GPC, and phosphatidylserine form a direct cognitive stack for cellular energy, cholinergic signaling, and neuronal membranes. All three actives reach meaningful amounts and create strong depth.

Alpha-GPC active yield and sourcing are not fully identified, but the disclosed amount is consistent with a useful active contribution. The compact powder avoids unrelated ingredients and keeps the mechanism clear.

Study evidence
Acetyl L-Carnitine Supportive 20 studies
Alpha-GPC Supportive 15 studies
Mental Focus
Mental Focus
Impact
Highest effect
A Goal FitA- Strength of SupportB+ CoverageA Formula Quality
Alpha-GPC · 600 mgAcetyl L-Carnitine · 850 mg

Acetyl-L-carnitine, Alpha-GPC, and phosphatidylserine form a direct and well-dosed cognitive stack. The combination supports brain energy, acetylcholine, and cell-membrane signaling rather than relying on general nutrition.

ALCAR HCl is clearly identified, and the estimated active Alpha-GPC amount reaches a preferred range. Alpha-GPC yield, sourcing, and broader purity testing are not fully documented.

Study evidence
Acetyl L-Carnitine Supportive 7 studies
Alpha-GPC Supportive 1 study
Brain Health
Brain Health
Impact
Highest effect
A Goal FitB+ Strength of SupportA- CoverageA Formula Quality
Alpha-GPC · 600 mg

The three-ingredient powder is strongly aligned with memory, attention, and brain energy support. Acetyl L-carnitine, Alpha-GPC, and phosphatidylserine address complementary cognitive mechanisms at meaningful amounts.

Alpha-GPC active yield and sourcing are not clarified, and the bulk powder may be vulnerable to moisture. The formula still offers unusually concentrated pathway coverage for someone comfortable with a scoop-based product.

Study evidence
Acetyl L-Carnitine Supportive 19 studies
Alpha-GPC Supportive 12 studies
Energy
Energy
Impact
Highest effect
B+ Goal FitA- Strength of SupportB+ CoverageA Formula Quality
Acetyl L-Carnitine · 850 mg

Acetyl L-carnitine supports mitochondrial fuel handling, while alpha-GPC and phosphatidylserine address focus and cognitive stamina. Human evidence supports these ingredients for selected cognitive or fatigue contexts, though results vary by population.

Acetyl L-carnitine at 850 mg, alpha-GPC at 600 mg, and phosphatidylserine at 150 mg are all material amounts. Every active and amount is clearly disclosed, although the alpha-GPC active yield is not specified.

Study evidence
Acetyl L-Carnitine Supportive 19 studies
Anti-Aging
Anti-Aging
Impact
Highest effect
B+ Goal FitA- Strength of SupportB CoverageA Formula Quality
Alpha-GPC · 600 mg

Acetyl L-carnitine, alpha-GPC, and phosphatidylserine create a focused combination for mitochondrial and cognitive support. All three actives reach meaningful amounts and address complementary aspects of brain function with age.

The formula does not cover structural or inflammatory pathways, and alpha-GPC source quality is not identified. Its high-dose, streamlined design favors depth over wide healthy-aging coverage.

Study evidence
Acetyl L-Carnitine Supportive 1 study
Alpha-GPC Not classified

No linked studies yet.

Metabolism Boost
Metabolism Boost
Impact
High effect
B- Goal FitA- Strength of SupportC CoverageA- Formula Quality
Acetyl L-Carnitine · 850 mg

Acetyl L-carnitine provides direct mitochondrial fuel-transport support at a solid amount. Alpha-GPC and phosphatidylserine mainly serve cognitive rather than metabolic goals.

The powder clearly discloses each active and gives acetyl L-carnitine useful dose depth. The product remains narrow for metabolism because it lacks thermogenic, thyroid, and glycemic actives.

Study evidence
Acetyl L-Carnitine Adverse 1 study

Ingredients

IngredientAmount per serving
Acetyl L-Carnitine HCl
850 mg
GlyceroPhosphoCholine
600 mg
Phosphatidylserine
150 mg
Gluten Free Adults 18–50 Dairy Free Sugar Free
Report overview
Acetyl L-Carnitine · 850 mg OverallScore79
A- Active Ingredient Quality & BioavailabilityA+ Dose, Safety & Label TransparencyF Value

The powder supplies ALCAR HCl at a solid standard-range dose. Its exact amount is clear, while no cGMP or purity-testing claim is supplied. The serving is costly for ALCAR alone, but well-dosed Alpha-GPC and phosphatidylserine add material value.

View ingredientView products
Alpha-GPC · 600 mg OverallScore47
F Active Ingredient Quality & BioavailabilityB+ Dose, Safety & Label TransparencyF Value

Generic Alpha-GPC is listed at 600 mg without source or active-yield clarification. Assuming 50% yield, the estimated 300 mg active amount reaches the preferred range. The estimated cost per active dose is exceptionally high for an unbranded product without protected delivery.

View ingredientView products
Loading alternative details
68 Performance

Acetyl-Choline Brain Food

NS Natural Stacks
<p>The more targeted formula provides 319 mg of acetyl-L-carnitine and 192 mg of alpha-GPC. It preserves both collection ingredients, though each amount is lower and phosphatidylserine is absent.</p>
84 Performance

Acetyl-L-Carnitine Arginate

Life Extension
<p>The more targeted formula provides acetyl-L-carnitine hydrochloride with an additional arginate form. The disclosed carnitine forms provide a focused alternative, but the combined amount is lower and both alpha-GPC and phosphatidylserine are absent.</p>
75 Performance

Alpha GPC 300 mg

NOW
<p>The more targeted formula provides 600 mg of alpha-GPC in a simple formula. It matches the original choline ingredient amount while omitting acetyl-L-carnitine and phosphatidylserine.</p>
76 Budget

Natural Brain Enhancers

Doctor's Best
<p>A lower-cost serving provides 300 mg of branded alpha-GPC and 100 mg of phosphatidylserine. It keeps two cognitive ingredients but halves the original alpha-GPC amount, lowers phosphatidylserine, and omits acetyl-L-carnitine.</p>
82 Budget

Optimized Carnitine

Life Extension
<p>A lower-cost serving provides 800 mg of acetyl-L-carnitine plus two additional carnitine forms. The carnitine coverage is broader and substantial, but alpha-GPC and phosphatidylserine are absent.</p>
71 Budget

Brain Sharp

The Vitamin Shoppe
<p>A lower-cost serving provides 500 mg of acetyl-L-carnitine and 200 mg of phosphatidylserine with several B vitamins. It improves the phosphatidylserine amount but lowers acetyl-L-carnitine and omits alpha-GPC.</p>
87 Value

Acetyl L-Carnitine 500 mg

Swanson
<p>The value-oriented formula provides 500 mg of clearly identified acetyl-L-carnitine hydrochloride. The simple formula costs far less but provides less carnitine and omits alpha-GPC and phosphatidylserine.</p>
77 Value

Cognitex Basics

Life Extension
<p>The value-oriented formula provides 250 mg of alpha-GPC and 100 mg of phosphatidylserine in a fat-containing formula. It retains two cognitive ingredients at lower amounts and omits acetyl-L-carnitine.</p>
84 Value

Acetyl L-Carnitine & Alpha-Lipoic Acid

Source Naturals
<p>The value-oriented formula provides 500 mg of acetyl-L-carnitine with 150 mg of alpha-lipoic acid. It adds a clearly disclosed companion ingredient but omits alpha-GPC and phosphatidylserine and provides less carnitine.</p>
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Oral acetyl-L-carnitine therapy reduces fatigue in overt hepatic encephalopathy: a randomized, double-blind, placebo-controlled study.
    Malaguarnera M; Vacante M; Giordano M; Pennisi G; Bella R; Rampello L; Malaguarnera M; Li Volti G; Galvano F · The American journal of clinical nutrition · 2011
    Randomized trial121 participantsEnergy forAcetyl L-Carnitine
  2. Carnitine for fatigue in multiple sclerosis.
    Tejani AM; Wasdell M; Spiwak R; Rowell G; Nathwani S · The Cochrane database of systematic reviews · 2010
    Systematic review1 studies pooledEnergy forAcetyl L-Carnitine
  3. Acetyl-L-carnitine improves cognitive functions in severe hepatic encephalopathy: a randomized and controlled clinical trial.
    Malaguarnera M; Vacante M; Motta M; Giordano M; Malaguarnera G; Bella R; Nunnari G; Rampello L; Pennisi G · Metabolic brain disease · 2012
    Randomized trial61 participantsBrain Health Cognitive Support forAcetyl L-Carnitine
  4. Mental impairment in aging: selection of patients, methods of evaluation and therapeutic possibilities of acetyl-L-carnitine.
    Passeri M; Iannuccelli M; Ciotti G; Bonati PA; Nolfe G; Cucinotta D · International journal of clinical pharmacology research · 1989
    Randomized trial30 participantsBrain Health forAcetyl L-Carnitine
  5. Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial.
    De Jesus Moreno Moreno M · Clinical therapeutics · 2003
    Randomized trial261 participantsBrain Health forAlpha-GPC
  6. Activity of Choline Alphoscerate on Adult-Onset Cognitive Dysfunctions: A Systematic Review and Meta-Analysis.
    Sagaro GG; Traini E; Amenta F · Journal of Alzheimer's disease : JAD · 2023
    Meta-analysis8 studies pooledBrain Health Cognitive Support forAlpha-GPC
  7. Acetyl-L-carnitine treatment in minimal hepatic encephalopathy.
    Malaguarnera M; Gargante MP; Cristaldi E; Vacante M; Risino C; Cammalleri L; Pennisi G; Rampello L · Digestive diseases and sciences · 2008
    Randomized trial125 participantsCognitive Support Brain Health forAcetyl L-Carnitine
  8. Acetyl L-carnitine slows decline in younger patients with Alzheimer's disease: a reanalysis of a double-blind, placebo-controlled study using the trilinear approach.
    Brooks JO; Yesavage JA; Carta A; Bravi D · International psychogeriatrics · 1998
    Randomized trial334 participantsCognitive Support forAcetyl L-Carnitine
  9. Comparative study of choline alfoscerate as a combination therapy with donepezil: A mixed double-blind randomized controlled and open-label observation trial.
    Lee W; Kim M · Medicine · 2024
    Randomized trial119 participantsCognitive Support Brain Health forAlpha-GPC
  10. Effect of Choline Alfoscerate on the Progression From Mild Cognitive Impairment to Dementia: Distributed Network Analysis of a Multicenter Korean Database Using a Common Data Model.
    Pyun JM; Lee I; Lee K; Kim MH; Park C; Yang HJ · Dementia and neurocognitive disorders · 2024
    Cohort study3,062 participantsCognitive Support forAlpha-GPC
  11. Acetyl-L-carnitine Slows the Progression from Prefrailty to Frailty in Older Subjects: A Randomized Interventional Clinical Trial.
    Malaguarnera G; Catania VE; Bertino G; Chisari LM; Castorina M; Bonfiglio C; Cauli O; Malaguarnera M · Current pharmaceutical design · 2022
    Randomized trial92 participantsAnti-Aging forAcetyl L-Carnitine
  12. Long-term acetyl-L-carnitine treatment in Alzheimer's disease.
    Spagnoli A; Lucca U; Menasce G; Bandera L; Cizza G; Forloni G; Tettamanti M; Frattura L; Tiraboschi P; Comelli M · Neurology · 1991
    Randomized trial130 participantsBrain Health Cognitive Support forAcetyl L-Carnitine
  13. Pharmaco-electroencephalographic and clinical effects of the cholinergic substance--acetyl-L-carnitine--in patients with organic brain syndrome.
    Herrmann WM; Dietrich B; Hiersemenzel R · International journal of clinical pharmacology research · 1990
    Randomized trialBrain Health forAcetyl L-Carnitine
  14. Acetyl-L-carnitine in the treatment of mildly demented elderly patients.
    Passeri M; Cucinotta D; Bonati PA; Iannuccelli M; Parnetti L; Senin U · International journal of clinical pharmacology research · 1990
    Randomized trial60 participantsBrain Health Mental Focus forAcetyl L-Carnitine
  15. Effects of choline alfoscerate on cognitive function and quality of life in type 2 diabetes: A double-blind, randomized, placebo-controlled trial.
    Sohn M; Park YH; Lim S · Diabetes, obesity & metabolism · 2025
    Randomized trial36 participantsBrain Health Cognitive Support forAlpha-GPC
  16. Acute Alpha-Glycerylphosphorylcholine Supplementation Enhances Cognitive Performance in Healthy Men.
    Kerksick CM · Nutrients · 2024
    Randomized trial20 participantsBrain Health Mental Focus Productivity Boost forAlpha-GPC
  17. A double-blind, parallel, multicenter comparison of L-acetylcarnitine with placebo on the attention deficit hyperactivity disorder in fragile X syndrome boys.
    Torrioli MG; Vernacotola S; Peruzzi L; Tabolacci E; Mila M; Militerni R; Musumeci S; Ramos FJ; Frontera M; Sorge G; Marzullo E; Romeo G; Vallee L; Veneselli E; Cocchi E; Garbarino E; Moscato U; Chiurazzi P; D'Iddio S; Calvani M; Neri G · American journal of medical genetics. Part A · 2008
    Randomized trial63 participantsCognitive Support forAcetyl L-Carnitine
  18. Acetyl L-carnitine (ALC) treatment in elderly patients with fatigue.
    Malaguarnera M; Gargante MP; Cristaldi E; Colonna V; Messano M; Koverech A; Neri S; Vacante M; Cammalleri L; Motta M · Archives of gerontology and geriatrics · 2008
    Randomized trial96 participantsCognitive Support forAcetyl L-Carnitine
  19. [Gliatilin in the Treatment of Cognitive Impairments Not Reaching the Level of Dementia: Meta-Analysis and Systematic Review].
    Voznyuk IA; Nepomnyashchiy IS; Kutkova AK; Tokareva DV; Prokhorova MV; Ovdiienko OA; Shusharina NN · Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · 2025
    Meta-analysis10 studies pooledCognitive Support forAlpha-GPC
  20. Vertical Association Between Dietary Total Choline and L-alpha-glycerylphosphorylcholine and the Cognitive Function in Chinese Adults Aged over 55, Result from China Health and Nutrition Survey 1997-2018.
    Guan F; Jia X; Huang F; Zhang J; Wei Y; Li L; Bai J; Wang H · Nutrients · 2024
    Cohort study7,659 participantsCognitive Support forAlpha-GPC
  21. The supplementation of acetyl-L-carnitine decreases fatigue and increases quality of life in patients with hepatitis C treated with pegylated interferon-α 2b plus ribavirin.
    Malaguarnera M; Vacante M; Bertino G; Neri S; Malaguarnera M; Gargante MP; Motta M; Lupo L; Chisari G; Bruno CM; Pennisi G; Bella R · Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research · 2012
    Randomized trial60 participantsEnergy forAcetyl L-Carnitine
  22. Acetyl-L-carnitine reduces depression and improves quality of life in patients with minimal hepatic encephalopathy.
    Malaguarnera M; Bella R; Vacante M; Giordano M; Malaguarnera G; Gargante MP; Motta M; Mistretta A; Rampello L; Pennisi G · Scandinavian journal of gastroenterology · 2011
    Randomized trial67 participantsEnergy forAcetyl L-Carnitine
  23. A prospective study to evaluate the efficacy and safety of oral acetyl-L-carnitine for the treatment of chemotherapy-induced peripheral neuropathy.
    Sun Y; Shu Y; Liu B; Liu P; Wu C; Zheng R; Zhang X; Zhuang Z; Deng Y; Zheng L; Xu Q; Jiang B; Ouyang X; Gao J; Xu N; Li X; Jiang S; Liang C; Yao Y · Experimental and therapeutic medicine · 2020
    Randomized trial239 participantsEnergy forAcetyl L-Carnitine
  24. Metabolomic biomarkers for (R, S)-ketamine and (S)-ketamine in treatment-resistant depression and healthy controls: A systematic review.
    Kumar R; Nuñez NA; Joshi N; Joseph B; Verde A; Seshadri A; Cuellar Barboza AB; Prokop LJ; Medeiros GC; Singh B · Bipolar disorders · 2024
    Systematic reviewEnergy forAcetyl L-Carnitine
  25. Acetyl-L-Carnitine Supplementation During HCV Therapy With Pegylated Interferon-α 2b Plus Ribavirin: Effect on Work Performance; A Randomized Clinical Trial.
    Malaguarnera G; Pennisi M; Gagliano C; Vacante M; Malaguarnera M; Salomone S; Drago F; Bertino G; Caraci F; Nunnari G; Malaguarnera M · Hepatitis monthly · 2014
    Randomized trial62 participantsMental Focus Productivity Boost forAcetyl L-Carnitine
  26. [Psycho-functional changes in attention and learning under the action of L-acetylcarnitine in 17 young subjects. A pilot study of its use in mental deterioration].
    Lino A; Boccia MM; Rusconi AC; Bellomonte L; Cocuroccia B · La Clinica terapeutica · 1992
    Non-randomized trial17 participantsMental Focus forAcetyl L-Carnitine
  27. Acetyl-L-carnitine (ALC) in attention-deficit/hyperactivity disorder: a multi-site, placebo-controlled pilot trial.
    Arnold LE; Amato A; Bozzolo H; Hollway J; Cook A; Ramadan Y; Crowl L; Zhang D; Thompson S; Testa G; Kliewer V; Wigal T; McBurnett K; Manos M · Journal of child and adolescent psychopharmacology · 2008
    Randomized trial112 participantsMental Focus forAcetyl L-Carnitine
  28. Acetyl-L-carnitine for patients with hepatic encephalopathy.
    Martí-Carvajal AJ; Gluud C; Arevalo-Rodriguez I; Martí-Amarista CE · The Cochrane database of systematic reviews · 2019
    Meta-analysis398 participants5 studies pooledMental Focus forAcetyl L-Carnitine
  29. Low Bioavailability and High TMAO Production: Novel Insights Into Acetylcarnitine and Carnitine Metabolism.
    Krims-Davis K; Ozola M; Razzivina V; Gukalova B; Konrade I; Dambrova M; Liepinsh E · Molecular nutrition & food research · 2025
    Randomized trialMetabolism Boost forAcetyl L-Carnitine
  30. Treatment of dementia with neurotransmission modulation.
    Doggrell SA; Evans S · Expert opinion on investigational drugs · 2004
    Narrative reviewProductivity Boost forAlpha-GPC